Ralf Gold

Publications

• Propionate Attenuates Atherosclerosis by Immune-dependent Regulation of Intestinal Cholesterol Metabolism
  European Heart Journal. Oct, 2021  |   Pubmed ID: 34597388
• Hospital Admissions for Neurodegenerative Diseases During the First Wave of the COVID-19 Pandemic: A Nationwide Cross-Sectional Study from Germany
  Brain Sciences. Sep, 2021  |   Pubmed ID: 34573238
• Report of a Fulminant Anti-pan-neurofascin-associated Neuropathy Responsive to Rituximab and Bortezomib
  Journal of the Peripheral Nervous System : JPNS. Sep, 2021  |   Pubmed ID: 34486194
• Maintenance Therapy with Subcutaneous Immunoglobulin in a Patient with Immune-mediated Neuropathic Postural Tachycardia Syndrome
  Journal of Translational Autoimmunity. 2021  |   Pubmed ID: 34471867
• Long-term Safety and Efficacy of Dimethyl Fumarate for Up to 13 years in Patients with Relapsing-remitting Multiple Sclerosis: Final ENDORSE Study Results
  Multiple Sclerosis (Houndmills, Basingstoke, England). Sep, 2021  |   Pubmed ID: 34465252
• Short- and Long-term Outcome of Patients with Spontaneous Echo Contrast or Thrombus in the Left Atrial Appendage in the Era of the Direct Acting Anticoagulants
  Clinical Research in Cardiology : Official Journal of the German Cardiac Society. Aug, 2021  |   Pubmed ID: 34436659
• COVID-19 MRNA Vaccine Induced Rhabdomyolysis and Fasciitis
  Journal of Neurology. Aug, 2021  |   Pubmed ID: 34435250
• Multiple Sclerosis is Not Associated with an Increased Risk for Severe COVID-19: a Nationwide Retrospective Cross-sectional Study from Germany
  Neurological Research and Practice. Aug, 2021  |   Pubmed ID: 34399858
• Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Inflammatory Syndrome in Seven Patients with Sarcoidosis: a Critical Discussion of Treatment and Prognosis
  Therapeutic Advances in Neurological Disorders. 2021  |   Pubmed ID: 34377151
• Multiple Sclerosis Therapy Consensus Group (MSTCG): Answers to the Discussion Questions
  Neurological Research and Practice. Aug, 2021  |   Pubmed ID: 34362473
• Corneal Inflammatory Cell Infiltration Predicts Disease Activity in Chronic Inflammatory Demyelinating Polyneuropathy
  Scientific Reports. 07, 2021  |   Pubmed ID: 34312451
• [Multiple Sclerosis Treatment Consensus Group (MSTCG): Position Paper on Disease-modifying Treatment of Multiple Sclerosis 2021 (white Paper)]
  Der Nervenarzt. Aug, 2021  |   Pubmed ID: 34297142
• The Impact of the COVID-19 Pandemic on Hospitalizations and Plasmapheresis Therapy in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: a Nationwide Analysis from Germany
  Therapeutic Advances in Neurological Disorders. 2021  |   Pubmed ID: 34285719
• An Algorithm Using Clinical Data to Predict the Optimal Individual Glucocorticoid Dosage to Treat Multiple Sclerosis Relapses
  Therapeutic Advances in Neurological Disorders. 2021  |   Pubmed ID: 34211583
• CMV Meningitis Associated with Dimethyl Fumarate Therapy-induced Lymphopenia in a Multiple Sclerosis Patient
  Journal of Neurology. Jun, 2021  |   Pubmed ID: 34175973
• Propionic Acid Rescues High-Fat Diet Enhanced Immunopathology in Autoimmunity Effects on Th17 Responses
  Frontiers in Immunology. 2021  |   Pubmed ID: 34140958
• Usefulness of Computed Tomographic Perfusion Imaging for Appropriate Diagnosis of Acute Cerebral Vessel Occlusion in Case of Anatomic Variations of the Circle of Willis
  Neurointervention. Jul, 2021  |   Pubmed ID: 34134184
• Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive Patients
  Neurology(R) Neuroimmunology & Neuroinflammation. 05, 2021  |   Pubmed ID: 34108267
• Age-dependent Favorable Visual Recovery Despite Significant Retinal Atrophy in Pediatric MOGAD: How Much Retina Do You Really Need to See Well?
  Journal of Neuroinflammation. May, 2021  |   Pubmed ID: 34051804
• Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis
  Frontiers in Immunology. 2021  |   Pubmed ID: 34012440
• Clinical Profiles and Mortality of COVID-19 Inpatients with Parkinson's Disease in Germany
  Movement Disorders : Official Journal of the Movement Disorder Society. 05, 2021  |   Pubmed ID: 33942924
• A Propagated Skeleton Approach to High Throughput Screening of Neurite Outgrowth for In Vitro Parkinson's Disease Modelling
  Cells. 04, 2021  |   Pubmed ID: 33920556
• Analysis of Nationwide Multimodal Complex Treatment and Drug Pump Therapy in Parkinson's Disease in Times of COVID-19 Pandemic in Germany
  Parkinsonism & Related Disorders. 04, 2021  |   Pubmed ID: 33845342
• Cross-sectional Area Reference Values for Peripheral Nerve Ultrasound in Adults: A Systematic Review and Meta-analysis-Part III: Cervical Nerve Roots and Vagal Nerve
  European Journal of Neurology. 07, 2021  |   Pubmed ID: 33838065
• Evaluation of the EFNS/PNS Diagnostic Criteria in a Cohort of CIDP Patients
  Annals of Clinical and Translational Neurology. 05, 2021  |   Pubmed ID: 33826247
• Improved Gastrointestinal Profile with Diroximel Fumarate is Associated with a Positive Impact on Quality of Life Compared with Dimethyl Fumarate: Results from the Randomized, Double-blind, Phase III EVOLVE-MS-2 Study
  Therapeutic Advances in Neurological Disorders. 2021  |   Pubmed ID: 33796143
• Cross-sectional Area Reference Values for Peripheral Nerve Ultrasound in Adults: A Systematic Review and Meta-analysis-Part II: Lower Extremity Nerves
  European Journal of Neurology. 07, 2021  |   Pubmed ID: 33794049
• Microstructural White Matter Alterations in Cognitively Impaired Patients at Early Stages of Multiple Sclerosis
  Clinical Neuroradiology. Mar, 2021  |   Pubmed ID: 33787958
• Treatment Response to Cyclophosphamide, Rituximab, and Bortezomib in Chronic Immune-mediated Sensorimotor Neuropathies: a Retrospective Cohort Study
  Therapeutic Advances in Neurological Disorders. 2021  |   Pubmed ID: 33747132
• [Disease-modifying Treatment of Secondary Progressive Multiple Sclerosis]
  Der Nervenarzt. Oct, 2021  |   Pubmed ID: 33656569
• Cross-sectional Area Reference Values for Peripheral Nerve Ultrasound in Adults: a Systematic Review and Meta-analysis-Part I: Upper Extremity Nerves
  European Journal of Neurology. 05, 2021  |   Pubmed ID: 33527596
• Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses
  Neurology(R) Neuroimmunology & Neuroinflammation. 03, 2021  |   Pubmed ID: 33468560
• Pain, Depression, and Quality of Life in Adults with MOG-antibody-associated Disease
  European Journal of Neurology. 05, 2021  |   Pubmed ID: 33423336
• Increased Muscle Echointensity Correlates with Clinical Disability and Muscle Strength in Chronic Inflammatory Demyelinating Polyneuropathy
  European Journal of Neurology. 05, 2021  |   Pubmed ID: 33404183
• Sunlight Exposure Exerts Immunomodulatory Effects to Reduce Multiple Sclerosis Severity
  Proceedings of the National Academy of Sciences of the United States of America. 01, 2021  |   Pubmed ID: 33376202
• Siponimod and Cognition in Secondary Progressive Multiple Sclerosis: EXPAND Secondary Analyses
  Neurology. 01, 2021  |   Pubmed ID: 33328324
• TDP-43 As Structure-based Biomarker in Amyotrophic Lateral Sclerosis
  Annals of Clinical and Translational Neurology. 01, 2021  |   Pubmed ID: 33263951
• New Approaches to Critical Illness Polyneuromyopathy: High-Resolution Neuromuscular Ultrasound Characteristics and Cytokine Profiling
  Neurocritical Care. 08, 2021  |   Pubmed ID: 33236290
• Siponimod: Disentangling Disability and Relapses in Secondary Progressive Multiple Sclerosis
  Multiple Sclerosis (Houndmills, Basingstoke, England). Sep, 2021  |   Pubmed ID: 33205682
• Chitinase 3-like 1 and Neurofilament Light Chain in CSF and CNS Atrophy in MS
  Neurology(R) Neuroimmunology & Neuroinflammation. 01, 2021  |   Pubmed ID: 33172960
• Serum Neurofilament Light Chain As Outcome Marker for Intensive Care Unit Patients
  Journal of Neurology. Apr, 2021  |   Pubmed ID: 33098034
• Course of Neuropsychological Impairment During Natalizumab-associated Progressive Multifocal Leukoencephalopathy
  European Journal of Neurology. 03, 2021  |   Pubmed ID: 33085811
• Cladribine Transfer into Human Milk: A Case Report
  Multiple Sclerosis (Houndmills, Basingstoke, England). 04, 2021  |   Pubmed ID: 32507055
• Developmental Venous Anomalies Are More Common in Patients with Multiple Sclerosis and Clinically Isolated Syndrome : Coincidence or Relevant?
  Clinical Neuroradiology. Mar, 2021  |   Pubmed ID: 31897504
• Lymphocyte Reconstitution After DMF Discontinuation in Clinical Trial and Real-world Patients with MS
  Neurology. Clinical Practice. Dec, 2020  |   Pubmed ID: 33510947
• Comprehensive Approaches for Diagnosis, Monitoring and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy
  Neurological Research and Practice. 2020  |   Pubmed ID: 33324942
• Severe Pneumonia with Formation of a Pulmonary Cavity Associated with Long-term Rituximab Therapy in Multiple Sclerosis
  Neurological Research and Practice. 2020  |   Pubmed ID: 33324932
• High-dose Biotin in Multiple Sclerosis: the End of the Road
  The Lancet. Neurology. 12, 2020  |   Pubmed ID: 33222766
• Dimethyl Fumarate Transfer into Human Milk
  Therapeutic Advances in Neurological Disorders. 2020  |   Pubmed ID: 33193814
• The Role of the Gut Microbiota and Microbial Metabolites in Neuroinflammation
  European Journal of Immunology. 12, 2020  |   Pubmed ID: 33188704
• Prior Treatment Status: Impact on the Efficacy and Safety of Teriflunomide in Multiple Sclerosis
  BMC Neurology. Oct, 2020  |   Pubmed ID: 33023488
• Delayed Diagnosis of Anti-Hu Antibodies in a Young Patient With Cerebellar Atrophy
  Pediatric Neurology. 10, 2020  |   Pubmed ID: 32951652
• Correlates of Polyneuropathy in Parkinson's Disease
  Annals of Clinical and Translational Neurology. 10, 2020  |   Pubmed ID: 32940017
• Multiple Sclerosis and Nutrition: Back to the Future?
  Therapeutic Advances in Neurological Disorders. 2020  |   Pubmed ID: 32863887
• Recovery from COVID-19 in a B-cell-depleted Multiple Sclerosis Patient
  Multiple Sclerosis (Houndmills, Basingstoke, England). 09, 2020  |   Pubmed ID: 32762494
• Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017
  Journal of Clinical Medicine. Jul, 2020  |   Pubmed ID: 32751888
• Genetic Determinants of the Humoral Immune Response in MS
  Neurology(R) Neuroimmunology & Neuroinflammation. 09, 2020  |   Pubmed ID: 32675288
• A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry
  Cancers. Jun, 2020  |   Pubmed ID: 32610669
• Parkinson's Disease Multimodal Complex Treatment (PD-MCT): Analysis of Therapeutic Effects and Predictors for Improvement
  Journal of Clinical Medicine. Jun, 2020  |   Pubmed ID: 32560079
• High-Resolution Nerve Ultrasound to Assess Nerve Echogenicity, Fascicular Count, and Cross-Sectional Area Using Semiautomated Analysis
  Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 07, 2020  |   Pubmed ID: 32521091
• Reader Response: Comparison of the Response to Rituximab Between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody Diseases
  Annals of Neurology. 08, 2020  |   Pubmed ID: 32495967
• Propionic Acid and Fasudil As Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease
  Molecules (Basel, Switzerland). May, 2020  |   Pubmed ID: 32481507
• Clinical Implications of Serum Neurofilament in Newly Diagnosed MS Patients: A Longitudinal Multicentre Cohort Study
  EBioMedicine. Jun, 2020  |   Pubmed ID: 32460167
• Long-term Safety and Efficacy of Daclizumab Beta in Relapsing-remitting Multiple Sclerosis: 6-year Results from the SELECTED Open-label Extension Study
  Journal of Neurology. Oct, 2020  |   Pubmed ID: 32451615
• Early Immunotherapy is Highly Effective in IgG1/IgG4 Positive IgLON5 Disease
  Journal of Neurology. Jul, 2020  |   Pubmed ID: 32444985
• Safety of Potential Breast Milk Exposure to IFN-β or Glatiramer Acetate: One-year Infant Outcomes
  Neurology(R) Neuroimmunology & Neuroinflammation. 07, 2020  |   Pubmed ID: 32434802
• Longitudinal Study on Nerve Ultrasound and Corneal Confocal Microscopy in NF155 Paranodopathy
  Annals of Clinical and Translational Neurology. 06, 2020  |   Pubmed ID: 32432402
• Safety and Efficacy of Delayed-release Dimethyl Fumarate in Patients with Relapsing-remitting Multiple Sclerosis: 9 Years' Follow-up of DEFINE, CONFIRM, and ENDORSE
  Therapeutic Advances in Neurological Disorders. 2020  |   Pubmed ID: 32426039
• Immunomodulatory and Anti-oxidative Effect of the Direct TRPV1 Receptor Agonist Capsaicin on Schwann Cells
  Journal of Neuroinflammation. May, 2020  |   Pubmed ID: 32375895
• Complete Epstein-Barr Virus Seropositivity in a Large Cohort of Patients with Early Multiple Sclerosis
  Journal of Neurology, Neurosurgery, and Psychiatry. 07, 2020  |   Pubmed ID: 32371533
• Is ε4 Associated with Cognitive Performance in Early MS?
  Neurology(R) Neuroimmunology & Neuroinflammation. 07, 2020  |   Pubmed ID: 32358224
• Monoclonal Antibody Treatment During Pregnancy And/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder
  Neurology(R) Neuroimmunology & Neuroinflammation. 07, 2020  |   Pubmed ID: 32327455
• Longitudinal Prevalence and Determinants of Pain in Multiple Sclerosis: Results from the German National Multiple Sclerosis Cohort Study
  Pain. 04, 2020  |   Pubmed ID: 32197038
• Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
  Cell. 03, 2020  |   Pubmed ID: 32160527
• Binding Patterns and Functional Properties of Human Antibodies to AQP4 and MOG on Murine Optic Nerve and Retina
  Journal of Neuroimmunology. Feb, 2020  |   Pubmed ID: 32143071
• Endocarditis Following Ocrelizumab in Relapsing-remitting MS
  Neurology(R) Neuroimmunology & Neuroinflammation. 05, 2020  |   Pubmed ID: 32014890
• DeepWAS: Multivariate Genotype-phenotype Associations by Directly Integrating Regulatory Information Using Deep Learning
  PLoS Computational Biology. 02, 2020  |   Pubmed ID: 32012148
• Dimethyl Fumarate Vs Fingolimod Following Different Pretreatments: A Retrospective Study
  Neurology(R) Neuroimmunology & Neuroinflammation. 03, 2020  |   Pubmed ID: 31937596
• Effects of IVIg Treatment on Autoantibody Testing in Neurological Patients: Marked Reduction in Sensitivity but Reliable Specificity
  Journal of Neurology. Mar, 2020  |   Pubmed ID: 31728710
• General Principles and Escalation Options of Immunotherapy in Autoantibody-associated Disorders of the CNS
  Neurological Research and Practice. 2019  |   Pubmed ID: 33324898
• Novel Variants in a Patient with Late-onset Hyperprolinemia Type II: Diagnostic Key for Status Epilepticus and Lactic Acidosis
  BMC Neurology. Dec, 2019  |   Pubmed ID: 31884946
• Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology
  Cells. 12, 2019  |   Pubmed ID: 31861253
• Smad7 in Intestinal CD4 T Cells Determines Autoimmunity in a Spontaneous Model of Multiple Sclerosis
  Proceedings of the National Academy of Sciences of the United States of America. 12, 2019  |   Pubmed ID: 31796589
• Temporal Dynamics of Diffusion Metrics in Early Multiple Sclerosis and Clinically Isolated Syndrome: A 2-Year Follow-Up Tract-Based Spatial Statistics Study
  Frontiers in Neurology. 2019  |   Pubmed ID: 31749760
• Progressive Multiple Sclerosis: Latest Therapeutic Developments and Future Directions
  Therapeutic Advances in Neurological Disorders. 2019  |   Pubmed ID: 31598138
• Elevated Levels of MiR-181c and MiR-633 in the CSF of Patients with MS: A Validation Study
  Neurology(R) Neuroimmunology & Neuroinflammation. 11, 2019  |   Pubmed ID: 31575652
• Induction of Regulatory Properties in the Intestinal Immune System by Dimethyl Fumarate in Lewis Rat Experimental Autoimmune Neuritis
  Frontiers in Immunology. 2019  |   Pubmed ID: 31552056
• Hereditary Defect of Cobalamin Metabolism with Adolescence Onset Resembling Multiple Sclerosis: 41-year Follow Up in Two Cases
  Therapeutic Advances in Neurological Disorders. 2019  |   Pubmed ID: 31489032
• Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis
  Frontiers in Neurology. 2019  |   Pubmed ID: 31428040
• Progressive Multiple Sclerosis: from Pathophysiology to Therapeutic Strategies
  Nature Reviews. Drug Discovery. 12, 2019  |   Pubmed ID: 31399729
• Extensive Immune Reconstitution Inflammatory Syndrome in Fingolimod-associated PML: a Case Report with 7 Tesla MRI Data
  BMC Neurology. Aug, 2019  |   Pubmed ID: 31399069
• Heterogeneous GBS Course Requires Standardized Guidelines
  Nature Reviews. Neurology. Oct, 2019  |   Pubmed ID: 31358946
• Neuroimaging Markers of Clinical Progression in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
  Therapeutic Advances in Neurological Disorders. 2019  |   Pubmed ID: 31244899
• Dynamics of Device-based Treatments for Parkinson's Disease in Germany from 2010 to 2017: Application of Continuous Subcutaneous Apomorphine, Levodopa-carbidopa Intestinal Gel, and Deep Brain Stimulation
  Journal of Neural Transmission (Vienna, Austria : 1996). 07, 2019  |   Pubmed ID: 31222604
• Antineuroinflammatory Drugs in HIV-associated Neurocognitive Disorders As Potential Therapy
  Neurology(R) Neuroimmunology & Neuroinflammation. 05, 2019  |   Pubmed ID: 31119186
• Three Cases of Non-carryover Fingolimod-PML: Is the Risk in Japan Increased?
  Neurology(R) Neuroimmunology & Neuroinflammation. 05, 2019  |   Pubmed ID: 31044147
• Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis
  JAMA Neurology. 07, 2019  |   Pubmed ID: 31034002
• Vitamin D Increases Glucocorticoid Efficacy Via Inhibition of MTORC1 in Experimental Models of Multiple Sclerosis
  Acta Neuropathologica. 09, 2019  |   Pubmed ID: 31030237
• Teriflunomide Real-world Evidence: Global Differences in the Phase 4 Teri-PRO Study
  Multiple Sclerosis and Related Disorders. Jun, 2019  |   Pubmed ID: 31005729
• Author Correction: Spatial and Temporal Heterogeneity of Mouse and Human Microglia at Single-cell Resolution
  Nature. Apr, 2019  |   Pubmed ID: 30918409
• A Protein Quality Control Pathway Regulated by Linear Ubiquitination
  The EMBO Journal. 05, 2019  |   Pubmed ID: 30886048
• Author Correction: Laquinimod Treatment in the R6/2 Mouse Model
  Scientific Reports. Mar, 2019  |   Pubmed ID: 30874566
• Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis
  Frontiers in Neurology. 2019  |   Pubmed ID: 30853935
• Intrathecal Triamcinolone Acetonide Exerts Anti-inflammatory Effects on Lewis Rat Experimental Autoimmune Neuritis and Direct Anti-oxidative Effects on Schwann Cells
  Journal of Neuroinflammation. Mar, 2019  |   Pubmed ID: 30851725
• Serum Neurofilaments Increase at Progressive Multifocal Leukoencephalopathy Onset in Natalizumab-treated Multiple Sclerosis Patients
  Annals of Neurology. 04, 2019  |   Pubmed ID: 30761586
• Spatial and Temporal Heterogeneity of Mouse and Human Microglia at Single-cell Resolution
  Nature. 02, 2019  |   Pubmed ID: 30760929
• Dynamics of Parkinson's Disease Multimodal Complex Treatment in Germany from 2010⁻2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers
  Cells. 02, 2019  |   Pubmed ID: 30754730
• Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease
  Cells. 01, 2019  |   Pubmed ID: 30708997
• Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson's Disease
  Cells. 01, 2019  |   Pubmed ID: 30699914
• Nerve Echogenicity and Intranerve CSA Variability in High-resolution Nerve Ultrasound (HRUS) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  Journal of Neurology. Feb, 2019  |   Pubmed ID: 30554264
• Emerging Immunotherapies for Parkinson Disease
  Neurology and Therapy. Jun, 2019  |   Pubmed ID: 30539376
• Can We Predict Cognitive Decline After Initial Diagnosis of Multiple Sclerosis? Results from the German National Early MS Cohort (KKNMS)
  Journal of Neurology. Feb, 2019  |   Pubmed ID: 30515631
• Clinical, Sonographic, and Electrophysiologic Longitudinal Features of Chronic Inflammatory Demyelinating Polyneuropathy
  Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 03, 2019  |   Pubmed ID: 30407676
• Peripheral CD19 B-cell Counts and Infusion Intervals As a Surrogate for Long-term B-cell Depleting Therapy in Multiple Sclerosis and Neuromyelitis Optica/neuromyelitis Optica Spectrum Disorders
  Journal of Neurology. Jan, 2019  |   Pubmed ID: 30377816
• Landscape of Pain in Parkinson's Disease: Impact of Gender Differences
  Neurological Research. Jan, 2019  |   Pubmed ID: 30311863
• Prospective Study of the Clinical, Electrophysiologic, and Sonographic Characteristics of Oxaliplatin-Induced Neuropathy
  Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 01, 2019  |   Pubmed ID: 30198601
• Association of Smoking but Not HLA-DRB1*15:01, APOE or Body Mass Index with Brain Atrophy in Early Multiple Sclerosis
  Multiple Sclerosis (Houndmills, Basingstoke, England). 04, 2019  |   Pubmed ID: 29532745
• Oral Therapies for Multiple Sclerosis
  Cold Spring Harbor Perspectives in Medicine. 01, 2019  |   Pubmed ID: 29500302
• Treatment of an Acute Motor and Sensory Axonal Neuropathy with Propionate in a 33-year-old Male
  Therapeutic Advances in Neurological Disorders. 2018  |   Pubmed ID: 30542375
• Successful Therapy with Rituximab in Three Patients with Probable Neurosarcoidosis
  Therapeutic Advances in Neurological Disorders. 2018  |   Pubmed ID: 30386436
• Patient-reported Outcomes in Patients with Relapsing Forms of MS Switching to Teriflunomide from Other Disease-modifying Therapies: Results from the Global Phase 4 Teri-PRO Study in Routine Clinical Practice
  Multiple Sclerosis and Related Disorders. Nov, 2018  |   Pubmed ID: 30273841
• Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients
  Frontiers in Neurology. 2018  |   Pubmed ID: 30131761
• Monitoring of Structural Changes in the Course of Acute Compressive Radial Neuropathies by Means of High Resolution Nerve Ultrasound
  Journal of the Neurological Sciences. 08, 2018  |   Pubmed ID: 30103969
• Flaccid Paralysis in Neuromyelitis Optica: An Atypical Presentation with Possible Involvement of the Peripheral Nervous System
  Multiple Sclerosis and Related Disorders. Oct, 2018  |   Pubmed ID: 30056360
• Ovarian Reserve in Women With Neuromyelitis Optica Spectrum Disorder
  Frontiers in Neurology. 2018  |   Pubmed ID: 29973905
• Breakthrough Treatment with Bortezomib for a Patient with Anti-NMDAR Encephalitis
  Clinical Neurology and Neurosurgery. 09, 2018  |   Pubmed ID: 29960102
• Detection of JC Virus Archetype in Cerebrospinal Fluid in a MS Patient with Dimethylfumarate Treatment Without Lymphopenia or Signs of PML
  Journal of Neurology. Aug, 2018  |   Pubmed ID: 29948248
• The NRF2 Pathway As Potential Biomarker for Dimethyl Fumarate Treatment in Multiple Sclerosis
  Annals of Clinical and Translational Neurology. Jun, 2018  |   Pubmed ID: 29928650
• DNA Methylation As a Mediator of HLA-DRB1*15:01 and a Protective Variant in Multiple Sclerosis
  Nature Communications. 06, 2018  |   Pubmed ID: 29921915
• Laquinimod Protects the Optic Nerve and Retina in an Experimental Autoimmune Encephalomyelitis Model
  Journal of Neuroinflammation. Jun, 2018  |   Pubmed ID: 29903027
• Correction To: Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
  CNS Drugs. 05, 2018  |   Pubmed ID: 29796978
• Alemtuzumab As Rescue Therapy in a Cohort of 50 Relapsing-remitting MS Patients with Breakthrough Disease on Fingolimod: a Multi-center Observational Study
  Journal of Neurology. Jul, 2018  |   Pubmed ID: 29696498
• Capsaicin-enriched Diet Ameliorates Autoimmune Neuritis in Rats
  Journal of Neuroinflammation. Apr, 2018  |   Pubmed ID: 29690884
• Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
  CNS Drugs. 03, 2018  |   Pubmed ID: 29600441
• Siponimod Versus Placebo in Secondary Progressive Multiple Sclerosis (EXPAND): a Double-blind, Randomised, Phase 3 Study
  Lancet (London, England). 03, 2018  |   Pubmed ID: 29576505
• High-resolution Nerve Ultrasound and Magnetic Resonance Neurography As Complementary Neuroimaging Tools for Chronic Inflammatory Demyelinating Polyneuropathy
  Therapeutic Advances in Neurological Disorders. 2018  |   Pubmed ID: 29552093
• Mechanical Thrombectomy in a Young Stroke Patient with Duchenne Muscular Dystrophy
  Therapeutic Advances in Neurological Disorders. 2018  |   Pubmed ID: 29552091
• Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36 (2014) 1958-1971]
  Clinical Therapeutics. 05, 2018  |   Pubmed ID: 29523369
• Treatment Choices and Neuropsychological Symptoms of a Large Cohort of Early MS
  Neurology(R) Neuroimmunology & Neuroinflammation. May, 2018  |   Pubmed ID: 29511705
• Clinical Commentary on 'Severe Hypertriglyceridemia Associated with Teriflunomide in a Patient with Multiple Sclerosis'
  Multiple Sclerosis (Houndmills, Basingstoke, England). 09, 2018  |   Pubmed ID: 29473795
• Activation of NPY-Y2 Receptors Ameliorates Disease Pathology in the R6/2 Mouse and PC12 Cell Models of Huntington's Disease
  Experimental Neurology. 04, 2018  |   Pubmed ID: 29309751
• Dietary Fatty Acids and Susceptibility to Multiple Sclerosis
  Multiple Sclerosis (Houndmills, Basingstoke, England). 01, 2018  |   Pubmed ID: 29307296
• Unexpected Additive Effects of Minocycline and Hydroxychloroquine in Models of Multiple Sclerosis: Prospective Combination Treatment for Progressive Disease?
  Multiple Sclerosis (Houndmills, Basingstoke, England). 10, 2018  |   Pubmed ID: 28857721
• Dimethyl Fumarate for Patients with Neuromyelitis Optica Spectrum Disorder
  Multiple Sclerosis (Houndmills, Basingstoke, England). 03, 2018  |   Pubmed ID: 28747147
• Role of Nuclear Factor (Erythroid-Derived 2)-Like 2 Signaling for Effects of Fumaric Acid Esters on Dendritic Cells
  Frontiers in Immunology. 2017  |   Pubmed ID: 29312359
• Lewis Rat Model of Experimental Autoimmune Encephalomyelitis
  Current Protocols in Neuroscience. Oct, 2017  |   Pubmed ID: 29058769
• Consistent Efficacy of Daclizumab Beta Across Patient Demographic and Disease Activity Subgroups in Patients with Relapsing-remitting Multiple Sclerosis
  Multiple Sclerosis and Related Disorders. Oct, 2017  |   Pubmed ID: 29055471
• Patient-reported Outcomes in Relapsing Forms of MS: Real-world, Global Treatment Experience with Teriflunomide from the Teri-PRO Study
  Multiple Sclerosis and Related Disorders. Oct, 2017  |   Pubmed ID: 29055438
• Bortezomib in Severe MuSK-antibody Positive Myasthenia Gravis: First Clinical Experience
  Therapeutic Advances in Neurological Disorders. Oct, 2017  |   Pubmed ID: 28966662
• Insight into Metabolic H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions
  Frontiers in Neurology. 2017  |   Pubmed ID: 28928709
• Impact of Combined Sodium Chloride and Saturated Long-chain Fatty Acid Challenge on the Differentiation of T Helper Cells in Neuroinflammation
  Journal of Neuroinflammation. Sep, 2017  |   Pubmed ID: 28899400
• Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM
  Clinical Therapeutics. Aug, 2017  |   Pubmed ID: 28751099
• Unilateral Right Prosopometamorphopsia with Positive "half-face-covering-test" After Small Occipitotemporal Stroke
  Journal of the Neurological Sciences. 08, 2017  |   Pubmed ID: 28716251
• Laquinimod Treatment in the R6/2 Mouse Model
  Scientific Reports. 07, 2017  |   Pubmed ID: 28694434
• Aquaporin-4 Antibodies in Patients Treated with Natalizumab for Suspected MS
  Neurology(R) Neuroimmunology & Neuroinflammation. Jul, 2017  |   Pubmed ID: 28642888
• Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and Neurodegeneration
  The American Journal of Pathology. Jul, 2017  |   Pubmed ID: 28634006
• Relevance of Early Cervical Cord Volume Loss in the Disease Evolution of Clinically Isolated Syndrome and Early Multiple Sclerosis: a 2-year Follow-up Study
  Journal of Neurology. Jul, 2017  |   Pubmed ID: 28600596
• Rho-associated Protein Kinase 2 (ROCK2): a New Target of Autoimmunity in Paraneoplastic Encephalitis
  Acta Neuropathologica Communications. 05, 2017  |   Pubmed ID: 28554330
• Management of Patients with Malignancies and Secondary Immunodeficiencies Treated with Immunoglobulins in Clinical Practice: Long-term Data of the SIGNS Study
  European Journal of Haematology. Aug, 2017  |   Pubmed ID: 28467615
• Metabolic Profiles by 1H-magnetic Resonance Spectroscopy in Natalizumab-associated Post-PML Lesions of Multiple Sclerosis Patients Who Survived Progressive Multifocal Leukoencephalopathy (PML)
  PloS One. 2017  |   Pubmed ID: 28445498
• Coronal Transcranial Sonography and M-Mode Tremor Frequency Determination in Parkinson's Disease and Essential Tremor
  Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 09, 2017  |   Pubmed ID: 28426143
• Two Years' Long-term Follow Up in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Efficacy of Intravenous Immunoglobulin Treatment
  Therapeutic Advances in Neurological Disorders. Feb, 2017  |   Pubmed ID: 28382108
• Treatment of Multiple Sclerosis During Pregnancy - Safety Considerations
  Expert Opinion on Drug Safety. May, 2017  |   Pubmed ID: 28333552
• Teriflunomide and Monomethylfumarate Target HIV-induced Neuroinflammation and Neurotoxicity
  Journal of Neuroinflammation. 03, 2017  |   Pubmed ID: 28284222
• Teaching Neuro: Sonographic Detection of Intraneural Perineurioma in Therapy-refractory Carpal Tunnel Syndrome
  Neurology. 03, 2017  |   Pubmed ID: 28265045
• Trigemino-autonomic Headache and Horner Syndrome As a First Sign of Granulomatous Hypophysitis
  Neurology(R) Neuroimmunology & Neuroinflammation. May, 2017  |   Pubmed ID: 28243612
• Progressive Spinal Cord Atrophy in Manifest and Premanifest Huntington's Disease
  Journal of Neurology, Neurosurgery, and Psychiatry. 07, 2017  |   Pubmed ID: 28209652
• Evidence of Activation of the Nrf2 Pathway in Multiple Sclerosis Patients Treated with Delayed-release Dimethyl Fumarate in the Phase 3 DEFINE and CONFIRM Studies
  Multiple Sclerosis (Houndmills, Basingstoke, England). Dec, 2017  |   Pubmed ID: 28156185
• Severe B-cell-mediated CNS Disease Secondary to Alemtuzumab Therapy
  The Lancet. Neurology. 02, 2017  |   Pubmed ID: 28102146
• Active Immunotherapy May Delay Disability in Progressive MS
  Journal of Neurology, Neurosurgery, and Psychiatry. 03, 2017  |   Pubmed ID: 27683917
• Predictors of Severity and Functional Outcome in Natalizumab-associated Progressive Multifocal Leukoencephalopathy
  Multiple Sclerosis (Houndmills, Basingstoke, England). 05, 2017  |   Pubmed ID: 27600113
• Listeria Rhombencephalitis Mimicking a Demyelinating Event in an Immunocompetent Young Patient
  Multiple Sclerosis (Houndmills, Basingstoke, England). 01, 2017  |   Pubmed ID: 27430683
• Long-term Effects of Delayed-release Dimethyl Fumarate in Multiple Sclerosis: Interim Analysis of ENDORSE, a Randomized Extension Study
  Multiple Sclerosis (Houndmills, Basingstoke, England). Feb, 2017  |   Pubmed ID: 27207449
• Role of the Receptor Mas in Macrophage-mediated Inflammation in Vivo
  Proceedings of the National Academy of Sciences of the United States of America. 12, 2016  |   Pubmed ID: 27872279
• Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis
  CNS Neuroscience & Therapeutics. 12, 2016  |   Pubmed ID: 27739247
• Amphiphysin-positive Paraneoplastic Myelitis and Stiff-person Syndrome
  Neurology(R) Neuroimmunology & Neuroinflammation. Dec, 2016  |   Pubmed ID: 27734022
• Safety and Tolerability Profile of Daclizumab in Patients with Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of Clinical Studies
  Multiple Sclerosis and Related Disorders. Sep, 2016  |   Pubmed ID: 27645341
• The Immunomodulatory Effect of Laquinimod in CNS Autoimmunity is Mediated by the Aryl Hydrocarbon Receptor
  Journal of Neuroimmunology. 09, 2016  |   Pubmed ID: 27609269
• Expression of Brain-derived Neurotrophic Factor in Astrocytes - Beneficial Effects of Glatiramer Acetate in the R6/2 and YAC128 Mouse Models of Huntington's Disease
  Experimental Neurology. Nov, 2016  |   Pubmed ID: 27587303
• "Punched Nerve Syndrome" As Contributing Factor for "Saturday Night Palsy"
  Journal of the Neurological Sciences. Sep, 2016  |   Pubmed ID: 27538626
• Charles Bonnet Syndrome Successfully Treated with Levetiracetam
  Journal of Neurology. Sep, 2016  |   Pubmed ID: 27485168
• Conclusions: Calls to Action for Improving the Life of MS Patients and Their Families
  Multiple Sclerosis (Houndmills, Basingstoke, England). 08, 2016  |   Pubmed ID: 27465617
• The Payer's Perspective: What is the Burden of MS and How Should the Patient's Perspective Be Integrated in Health Technology Assessment Conducted for Taking Decisions on Access to Care and Treatment?
  Multiple Sclerosis (Houndmills, Basingstoke, England). 08, 2016  |   Pubmed ID: 27465616
• The Clinical Perspective: How to Personalise Treatment in MS and How May Biomarkers Including Imaging Contribute to This?
  Multiple Sclerosis (Houndmills, Basingstoke, England). 08, 2016  |   Pubmed ID: 27465613
• Introduction: Do We Need Multi-stakeholder Colloquia in MS?
  Multiple Sclerosis (Houndmills, Basingstoke, England). 08, 2016  |   Pubmed ID: 27465611
• Safety and Efficacy of Daclizumab in Relapsing-remitting Multiple Sclerosis: 3-year Results from the SELECTED Open-label Extension Study
  BMC Neurology. Jul, 2016  |   Pubmed ID: 27461166
• Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program
  Neurology and Therapy. Dec, 2016  |   Pubmed ID: 27411694
• Novel Multiple Sclerosis Susceptibility Loci Implicated in Epigenetic Regulation
  Science Advances. Jun, 2016  |   Pubmed ID: 27386562
• Treatment of Patients with Multifocal Motor Neuropathy with Immunoglobulins in Clinical Practice: the SIGNS Registry
  Therapeutic Advances in Neurological Disorders. May, 2016  |   Pubmed ID: 27134672
• Tocilizumab, MS, and NMOSD
  Multiple Sclerosis (Houndmills, Basingstoke, England). 12, 2016  |   Pubmed ID: 27068554
• Plasmapheresis and Immunoadsorption in Patients with Steroid Refractory Multiple Sclerosis Relapses
  Journal of Neurology. Jun, 2016  |   Pubmed ID: 27039388
• High Salt Drives Th17 Responses in Experimental Autoimmune Encephalomyelitis Without Impacting Myeloid Dendritic Cells
  Experimental Neurology. May, 2016  |   Pubmed ID: 26976739
• Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome
  JAMA Neurology. 05, 2016  |   Pubmed ID: 26954938
• Basal Ganglia Alterations Appearing in Transcranial Sonography Prior to MRI in a Patient with Creutzfeld-Jacob Disease
  Journal of the Neurological Sciences. Mar, 2016  |   Pubmed ID: 26944174
• Relevance of Endoglin, IL-1α, IL-1β and Anti-ovarian Antibodies in Females with Multiple Sclerosis
  Journal of the Neurological Sciences. Mar, 2016  |   Pubmed ID: 26944156
• Transorbital Sonography in CIDP Patients: No Evidence for Optic Nerve Hypertrophy
  Journal of the Neurological Sciences. Mar, 2016  |   Pubmed ID: 26944149
• Interferon-beta Exposure During First Trimester is Safe in Women with Multiple Sclerosis-A Prospective Cohort Study from the German Multiple Sclerosis and Pregnancy Registry
  Multiple Sclerosis (Houndmills, Basingstoke, England). 05, 2016  |   Pubmed ID: 26920382
• Glatiramer Acetate During Early Pregnancy: A Prospective Cohort Study
  Multiple Sclerosis (Houndmills, Basingstoke, England). 05, 2016  |   Pubmed ID: 26754804
• Hypoechogenicity of Brainstem Raphe Nuclei is Associated with Increased Attack Frequency in Episodic Migraine
  Cephalalgia : an International Journal of Headache. Jul, 2016  |   Pubmed ID: 26566936
• PML Risk Stratification Using Anti-JCV Antibody Index and L-selectin
  Multiple Sclerosis (Houndmills, Basingstoke, England). Jul, 2016  |   Pubmed ID: 26432858
• Tumefactive Multiple Sclerosis Lesions in Two Patients After Cessation of Fingolimod Treatment
  Therapeutic Advances in Neurological Disorders. Sep, 2015  |   Pubmed ID: 26557898
• Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-related Hospitalizations: Integrated Analysis of the Delayed-release Dimethyl Fumarate Phase III Studies
  Clinical Therapeutics. Nov, 2015  |   Pubmed ID: 26526385
• Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array
  Genetic Epidemiology. Dec, 2015  |   Pubmed ID: 26497834
• Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity Via the Small Intestine
  Immunity. Oct, 2015  |   Pubmed ID: 26488817
• Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses
  JAMA Neurology. Oct, 2015  |   Pubmed ID: 26322399
• Low Dose Fumaric Acid Esters Are Effective in a Mouse Model of Spontaneous Chronic Encephalomyelitis
  Journal of Neuroimmunology. Aug, 2015  |   Pubmed ID: 26198914
• Dagibatran Etexilate: Is There Any Need for Coagulation Monitoring After Initiation?
  The Neurologist. Jul, 2015  |   Pubmed ID: 26185953
• Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness
  PloS One. 2015  |   Pubmed ID: 26114298
• Combinations of Susceptibility Genes Are Associated with Higher Risk for Multiple Sclerosis and Imply Disease Course Specificity
  PloS One. 2015  |   Pubmed ID: 26011527
• Glial Cells Express Nuclear Nrf2 After Fumarate Treatment for Multiple Sclerosis and Psoriasis
  Neurology(R) Neuroimmunology & Neuroinflammation. Jun, 2015  |   Pubmed ID: 25866832
• Efficacy of Delayed-release Dimethyl Fumarate in Relapsing-remitting Multiple Sclerosis: Integrated Analysis of the Phase 3 Trials
  Annals of Clinical and Translational Neurology. Feb, 2015  |   Pubmed ID: 25750916
• MHCII-independent CD4+ T Cells Protect Injured CNS Neurons Via IL-4
  The Journal of Clinical Investigation. Feb, 2015  |   Pubmed ID: 25607842
• Increase of Angiotensin II Type 1 Receptor Auto-antibodies in Huntington's Disease
  Molecular Neurodegeneration. Nov, 2014  |   Pubmed ID: 25398321
• Rituximab Postprogressive Multifocal Leukoencephalopathy: a Feasible Therapeutic Option in Selected Cases
  Therapeutic Advances in Neurological Disorders. Nov, 2014  |   Pubmed ID: 25371711
• High Noon Back Pain- Severe Pseudoradicular Pain As a Lead Symptom of Superficial Siderosis: a Case Report
  Therapeutic Advances in Neurological Disorders. Nov, 2014  |   Pubmed ID: 25371709
• Fumarate Treatment in Progressive Forms of Multiple Sclerosis: First Results of a Single-center Observational Study
  Therapeutic Advances in Neurological Disorders. Sep, 2014  |   Pubmed ID: 25342977
• Magnetization Transfer Ratio in the Delayed-release Dimethyl Fumarate DEFINE Study
  Journal of Neurology. Dec, 2014  |   Pubmed ID: 25270680
• Effects of Delayed-release Dimethyl Fumarate on MRI Measures in the Phase 3 DEFINE Study
  Journal of Neurology. Sep, 2014  |   Pubmed ID: 24989666
• Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis
  Journal of Central Nervous System Disease. 2014  |   Pubmed ID: 24855407
• Highly Immunoreactive IgG Antibodies Directed Against a Set of Twenty Human Proteins in the Sera of Patients with Amyotrophic Lateral Sclerosis Identified by Protein Array
  PloS One. 2014  |   Pubmed ID: 24586901
• Prophylactic Antiepileptic Treatment Reduces Seizure Frequency in Natalizumab-associated Progressive Multifocal Leukoencephalopathy
  Therapeutic Advances in Neurological Disorders. Jan, 2014  |   Pubmed ID: 24409198
• Detection of Patient Subgroups with Differential Expression in Omics Data: a Comprehensive Comparison of Univariate Measures
  PloS One. 2013  |   Pubmed ID: 24278130
• Sex and Gender Issues in Multiple Sclerosis
  Therapeutic Advances in Neurological Disorders. Jul, 2013  |   Pubmed ID: 23858327
• Improving the Default Data Analysis Workflow for Large Autoimmune Biomarker Discovery Studies with ProtoArrays
  Proteomics. Jul, 2013  |   Pubmed ID: 23616427
• Disease Course and Outcome of 15 Monocentrically Treated Natalizumab-associated Progressive Multifocal Leukoencephalopathy Patients
  Journal of Neurology, Neurosurgery, and Psychiatry. Oct, 2013  |   Pubmed ID: 23606731
• Ventricular Tachycardia During Basilar-type Migraine Attack
  Therapeutic Advances in Neurological Disorders. Jan, 2013  |   Pubmed ID: 23277791
• Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation Via Fumaric Acid Esters
  International Journal of Molecular Sciences. 2012  |   Pubmed ID: 23109883
• Multiple Sclerosis and Pregnancy: Experience from a Nationwide Database in Germany
  Therapeutic Advances in Neurological Disorders. Sep, 2012  |   Pubmed ID: 22973421
• TNF Receptor 1 Genetic Risk Mirrors Outcome of Anti-TNF Therapy in Multiple Sclerosis
  Nature. Aug, 2012  |   Pubmed ID: 22801493
• Potassium Channel KIR4.1 As an Immune Target in Multiple Sclerosis
  The New England Journal of Medicine. Jul, 2012  |   Pubmed ID: 22784115
• Incidence of Therapy-related Acute Leukaemia in Mitoxantrone-treated Multiple Sclerosis Patients in Germany
  Therapeutic Advances in Neurological Disorders. Mar, 2012  |   Pubmed ID: 22435072
• Constitutive Activity of NF-kappa B in Myeloid Cells Drives Pathogenicity of Monocytes and Macrophages During Autoimmune Neuroinflammation
  Journal of Neuroinflammation. Jan, 2012  |   Pubmed ID: 22260436
• Central Nervous System Rather Than Immune Cell-derived BDNF Mediates Axonal Protective Effects Early in Autoimmune Demyelination
  Acta Neuropathologica. Feb, 2012  |   Pubmed ID: 22009304
• Standard and Escalating Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
  Therapeutic Advances in Neurological Disorders. May, 2011  |   Pubmed ID: 21694819
• Functional Energetics of CD4+-cellular Immunity in Monoclonal Antibody-associated Progressive Multifocal Leukoencephalopathy in Autoimmune Disorders
  PloS One. 2011  |   Pubmed ID: 21533133
• Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease
  PloS One. Jan, 2011  |   Pubmed ID: 21297955
• Depression in Patients with Huntington Disease Correlates with Alterations of the Brain Stem Raphe Depicted by Transcranial Sonography
  Journal of Psychiatry & Neuroscience : JPN. May, 2011  |   Pubmed ID: 21138658
• Anti-inflammatory Effects of the Anticonvulsant Drug Levetiracetam on Electrophysiological Properties of Astroglia Are Mediated Via TGFβ1 Regulation
  British Journal of Pharmacology. Jan, 2011  |   Pubmed ID: 20955362
• Discordant Findings in Color-coded Duplex-sonography and Magnetic Resonance Angiography in Symptomatic Internal Carotid Artery Stenosis: Implications for Diagnostic Work-up and Early Intervention
  Therapeutic Advances in Neurological Disorders. Jan, 2010  |   Pubmed ID: 21180637
• Evolving Expectations Around Early Management of Multiple Sclerosis
  Therapeutic Advances in Neurological Disorders. Nov, 2010  |   Pubmed ID: 21179596
• Natalizumab and Progressive Multifocal Leukoencephalopathy: What Are the Causal Factors and Can It Be Avoided?
  Archives of Neurology. Aug, 2010  |   Pubmed ID: 20697042
• Translational Research in Neurology and Neuroscience 2010: Multiple Sclerosis
  Archives of Neurology. Nov, 2010  |   Pubmed ID: 20625066
• The Impact of Fingolimod (FTY720) in Neuroimmunologic Diseases: Mechanisms Beyond Immunomodulation
  The American Journal of Pathology. Jun, 2010  |   Pubmed ID: 20395429
• Role of the Renin-angiotensin System in Autoimmune Inflammation of the Central Nervous System
  Proceedings of the National Academy of Sciences of the United States of America. Sep, 2009  |   Pubmed ID: 19706425
• Rapid Regulatory T-cell Response Prevents Cytokine Storm in CD28 Superagonist Treated Mice
  PloS One. 2009  |   Pubmed ID: 19247496
• Current and Future Standards in Treatment of Myasthenia Gravis
  Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. Oct, 2008  |   Pubmed ID: 19019304
• Re-expression of a Developmentally Restricted Potassium Channel in Autoimmune Demyelination: Kv1.4 is Implicated in Oligodendroglial Proliferation
  The American Journal of Pathology. Aug, 2007  |   Pubmed ID: 17600124
• Error Processing in Huntington's Disease
  PloS One. Dec, 2006  |   Pubmed ID: 17183717